Literature DB >> 27481429

Complete Response of Hepatocellular Carcinoma in a Patient With End-stage Liver Disease treated With Nivolumab: Whishful thinking or Possible?

Joerg Trojan1,2,3, Christoph Sarrazin1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27481429     DOI： 10.1038/ajg.2016.214

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  6 in total

1.  EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma.

Authors: 
Journal:  J Hepatol       Date:  2012-04       Impact factor: 25.083

Review 2.  Novel drugs in clinical development for hepatocellular carcinoma.

Authors:  Oliver Waidmann; Jörg Trojan
Journal:  Expert Opin Investig Drugs       Date:  2015-06-24       Impact factor: 6.206

3.  Prognosis of untreated hepatocellular carcinoma.

Authors:  Edoardo G Giannini; Fabio Farinati; Francesca Ciccarese; Anna Pecorelli; Gian Lodovico Rapaccini; Mariella Di Marco; Luisa Benvegnù; Eugenio Caturelli; Marco Zoli; Franco Borzio; Maria Chiaramonte; Franco Trevisani
Journal:  Hepatology       Date:  2014-11-26       Impact factor: 17.425

4.  Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study.

Authors:  Alessandro Vitale; Rafael Ramirez Morales; Giacomo Zanus; Fabio Farinati; Patrizia Burra; Paolo Angeli; Anna Chiara Frigo; Paolo Del Poggio; Gianludovico Rapaccini; Maria Anna Di Nolfo; Luisa Benvegnù; Marco Zoli; Franco Borzio; Edoardo Giovanni Giannini; Eugenio Caturelli; Maria Chiaramonte; Franco Trevisani; Umberto Cillo
Journal:  Lancet Oncol       Date:  2011-06-16       Impact factor: 41.316

5.  Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression.

Authors:  Martina Sanlorenzo; Igor Vujic; Adil Daud; Alain Algazi; Matthew Gubens; Sara Alcántara Luna; Kevin Lin; Pietro Quaglino; Klemens Rappersberger; Susana Ortiz-Urda
Journal:  JAMA Dermatol       Date:  2015-11       Impact factor: 10.282

Review 6.  Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go?

Authors:  Hashem B El-Serag; Fasiha Kanwal
Journal:  Hepatology       Date:  2014-08-25       Impact factor: 17.425
  6 in total
  5 in total

1.  Feasibility of immunotherapy in cancer patients with persistent or past hepatitis B or C virus infection.

Authors:  Tasuku Nakabori; Yutaro Abe; Sena Higashi; Takeru Hirao; Yasuharu Kawamoto; Shingo Maeda; Kazuma Daiku; Makiko Urabe; Yugo Kai; Ryoji Takada; Takuo Yamai; Kenji Ikezawa; Hiroyuki Uehara; Kazuyoshi Ohkawa
Journal:  JGH Open       Date:  2022-04-22

2.  Feasibility and safety of nivolumab in advanced hepatocellular carcinoma: real-life experience from three German centers.

Authors:  Fabian Finkelmeier; Carolin Czauderna; Lukas Perkhofer; Thomas J Ettrich; Jörg Trojan; Arndt Weinmann; Jens U Marquardt; Johannes Vermehren; Oliver Waidmann
Journal:  J Cancer Res Clin Oncol       Date:  2018-10-29       Impact factor: 4.553

3.  Safety and efficacy of immune checkpoint inhibitors in patients with HBV/HCV infection and advanced-stage cancer: A systematic review.

Authors:  Dan Pu; Liyuan Yin; Yuwen Zhou; Wen Li; Lin Huang; Liang Cai; Qinghua Zhou
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.889

4.  Immunotherapy in Hepatocellular Cancer Patients with Mild to Severe Liver Dysfunction: Adjunctive Role of the ALBI Grade.

Authors:  David J Pinato; Takahiro Kaneko; Anwaar Saeed; Tiziana Pressiani; Ahmed Kaseb; Yinghong Wang; David Szafron; Tomi Jun; Sirish Dharmapuri; Abdul Rafeh Naqash; Mahvish Muzaffar; Musharraf Navaid; Chieh-Ju Lee; Anushi Bulumulle; Bo Yu; Sonal Paul; Neil Nimkar; Dominik Bettinger; Hannah Hildebrand; Yehia I Abugabal; Celina Ang; Thomas U Marron; Uqba Khan; Nicola Personeni; Lorenza Rimassa; Yi-Hsiang Huang
Journal:  Cancers (Basel)       Date:  2020-07-10       Impact factor: 6.639

5.  Clinicopathological and Prognostic Value of Programmed Cell Death 1 Expression in Hepatitis B Virus-related Hepatocellular Carcinoma: A Meta-analysis.

Authors:  Zi-Yu Zhou; Shao-Ru Liu; Lei-Bo Xu; Chao Liu; Rui Zhang
Journal:  J Clin Transl Hepatol       Date:  2021-05-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.